World of DTC Marketing

MAY 7, 2021

The Washington Post reported last year that health and pharmaceutical companies spent almost $1 billion on just Facebook mobile ads in 2019. Marketers have an important role with patients. A complete waste of money, time and effort.

Media 283

Media Prescription Marketing Pharma 283

World of DTC Marketing

MARCH 1, 2022

Hospitals, physicians, and clinical care made up more than half of the total healthcare spending in 2019. According to federal data, annual per-person spending growth for workplace health insurance has exceeded the spending growth among Medicare and Medicaid patients in nine of the past 13 years. Half of U.S.

Insurance 154

Insurance Prescription Healthcare Healthcare 154

World of DTC Marketing

JUNE 22, 2022

Between 2019 and 2021, Alphabet’s venture-capital arms, Google Ventures, and Gradient Ventures, and its private-equity unit, CapitalG, made about 100 deals, a quarter of Alphabet’s combined total, in life sciences and health care. Google launched itself into the wearables business in 2019 with a $2.1bn acquisition of Fitbit.

Healthcare 227

Healthcare Healthcare Food and Drug Administration FDA 227

World of DTC Marketing

NOVEMBER 18, 2021

I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.

Pharma 202

Pharma Medicine Prescription Manufacturing 202

World of DTC Marketing

APRIL 12, 2022

Many medical professionals, consumer advocates, and academics say that quality and access to care are declining as the industry consolidates and closes smaller practices in poor or rural areas, pushes doctors to increase volumes of patients seen, and encourages more expensive diagnostic tests and the use of less costly equipment.

Healthcare 209

Healthcare Healthcare Insurance Physicians 209

World of DTC Marketing

JANUARY 12, 2022

The word influencer was added to the Merriam-Webster dictionary in 2019, but influencer marketing is nothing new. People are turning to their favorite Instagram stars, Twitter personalities, and YouTubers for advice and recommendations on purchasing decisions, but does this apply to prescription drugs? bil­lion in 2021.

Marketing 192

Marketing Pharma Side effects Media 192

World of DTC Marketing

DECEMBER 2, 2020

How is pharma going to get patients back into to ask their doctor about branded medications? Health spending for the calendar year may end up lower than it was in 2019 but spending on prescription drugs has not fallen which could be due to price increases. This is especially true for undiagnosed patients.

Marketing 155

Marketing Doctors Physicians Prescription 155

World of DTC Marketing

MAY 30, 2021

Google has signed an agreement with the Mayo clinic to help analyze data as they want a slice of healthcare dollars but what’s missing from these tech companies is “the human touch” that patients want. The problem is that VC sees opportunities that don’t necessarily align with patients’ needs.

Healthcare 198

Healthcare Healthcare Insurance Medical 198

World of DTC Marketing

MAY 24, 2022

Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. In 2019 alone, almost 20 percent of the United States population, nearly 50 million people, were diagnosed with a mental illness.

Patients 252

Patients Prescription Medical Marketing 252

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. COVID-19 has not impacted the number of launches in the oncology space, as 2020 and 2021 have seen similar rates of drug launches as in 2019.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

World of DTC Marketing

JANUARY 21, 2021

According to 2019 Pew Research Center data , 90% of males in the United States use the internet followed by 89% of females (Pew, 2019). In the year 2018, approximately 92% of urban residents are internet users, 90% resided in suburban communities, and 78% resided in rural communities (Pew, 2019).

Pharma 180

Pharma Sales tools Medical Media 180

Pharma Marketing Network

MARCH 3, 2021

But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative? Reassess the Patient Journey. Enhance Patient Services Programs. Here, we offer four ways pharma marketers can help.

Patients 88

Patients Physicians Pharma Insurance 88

Pharmacy Times

AUGUST 17, 2022

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

Prescription 49

Prescription Patients 49

pharmaphorum

JUNE 27, 2022

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories.

Biopharma 110

Biopharma Sales Prescription FDA 110

Clarify Health

MAY 11, 2022

Pfizer partnered with Clarify Health for a real-world study assessing medication adherence to tafamidis among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that real-world adherence to tafamidis in patients with ATTR-CM was high. Get valuable Insights delivered to your inbox.

Medical 52

Medical Patients Prescription FDA 52

pharmaphorum

AUGUST 11, 2022

Zantac was originated by GSK and launched by the company in the early 1908s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion over the years.

Sales 105

Sales Prescription FDA Marketing 105

Pharma Marketing Network

MARCH 3, 2021

But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative? Reassess the Patient Journey. Enhance Patient Services Programs. Here, we offer four ways pharma marketers can help.

Patients 52

Patients Physicians Pharma Insurance 52

pharmaphorum

JANUARY 24, 2023

Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients’ homes in return for a $5 monthly fee. The drugs can be delivered on either a monthly or quarterly basis, depending on the needs of patients.

Prescription 59

Prescription Insurance Retail Medical 59

Clarify Health

MAY 11, 2022

Clarify Health published a real-world study assessing medication adherence among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that real-world adherence to the treatment in patients with ATTR-CM was high. Read the full study published in Patient Preference and Adherence.

Medical 40

Medical Patients Prescription FDA 40

Clarify Health

MAY 11, 2022

Clarify Health published a real-world study assessing medication adherence among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that real-world adherence to the treatment in patients with ATTR-CM was high. Read the full study published in Patient Preference and Adherence.

Medical 40

Medical Patients Prescription FDA 40

PM360

JUNE 24, 2024

1 Yet, due to its very nature most of these patients face a long and complex journey towards a diagnosis and treatment. Challenges may include being mis-diagnosed, frequently resulting in patients having to travel long distances to the specialists they need and many having to uproot themselves and family members to be closer to medical care.

Education 52

Education Patients Insurance Prescription 52

Medgadget

MAY 2, 2023

The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution.

Side effects 86

Side effects Prescription Healthcare Healthcare 86

pharmaphorum

DECEMBER 7, 2022

Pharma companies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought by patients who claim the drug caused them to develop cancer.

Sales 75

Sales Prescription FDA Pharma 75

PM360

AUGUST 29, 2022

Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. During the launch phase of a new Rx product, building brand awareness is paramount to driving eventual prescription lift. Diabetes Advertising Remains Prevalent.

Pharma 98

Pharma Prescription Marketing Pharmaceutical Sales 98

Clarivate

DECEMBER 14, 2021

As the COVID-19 pandemic continues to evolve, we are seeing substantial shifts in the way patients access healthcare and how providers deliver care. 2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. hours seeing patients.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products. Competing against Restasis are Novartis’ Xiidra (lifitegrast ophthalmic solution 5%), which launched in the US in 2016, and Sun Pharma’s Cequa (cyclosporine ophthalmic solution 0.09%), which launched in the US in 2019.

Prescription 59

Prescription Physicians FDA Marketing 59

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Clarify Health

JANUARY 19, 2021

Understanding how patients are using telehealth is essential for our healthcare system to be able to optimize how it delivers care. Are elderly patients more or less likely than non-elderly patients to use telehealth? Are primary care visits more or less likely to be conducted virtually compared to specialist visits?

Insurance 52

Insurance Healthcare Healthcare Patients 52

pharmaphorum

NOVEMBER 14, 2022

A study of public tenders for prescription medicines between 2014 and 2019 shows a fall in multi-criteria tenders rewarding “environmental” attributes and an average weighting of only 5% (see Figure 2). This way, we can ensure that every person, as well as every fraction of a degree, will matter in the decades to come.

Medicine 105

Medicine Pharmaceutical Healthcare Healthcare 105

pharmaphorum

SEPTEMBER 6, 2022

billion in 2019. We believe that companies like Bayer consumer health have a responsibility to provide trustworthy, evidence-based solutions to the consumer’s non-prescription healthcare needs, using our deep understanding of biology and consumer needs to deliver innovative products – and keeping on top of changing needs and paradigms.

Healthcare 90

Healthcare Healthcare Safety Medical 90

Clarivate

OCTOBER 25, 2023

of fee-for-service beneficiaries having a type 2 diabetes diagnosis in 2019 , it is among the most widespread chronic conditions in the over-65 population. While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

MAY 11, 2023

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process.

Marketing 52

Marketing Patients Management Insurance 52

PM360

JULY 21, 2022

Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. 2 The percentage of healthcare providers willing to see pharmaceutical company reps in person had declined from 67% in 2018 to 54% in 2019. Updated September 17, 2019.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

European Pharmaceutical Review

NOVEMBER 15, 2022

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.” Takeaways from ISPE’s GAMP 5 Second Edition update.

Manufacturing 98

Manufacturing Pharma Food and Drug Administration Safety 98

Nixon Gwilt Law

APRIL 28, 2022

If their products require a prescription, they will partner with providers, but they do not hold themselves out as healthcare providers. In this model, the outward facing “brand” – e.g. Teladoc – is used by the MSO and may be incorporated into the entity names of individual clinics through which the actual patient care services are delivered.

Marketing 52

Marketing Networking Management Physicians 52

Pharmaceutical Representative Training

JANUARY 29, 2025

These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition. The Cost-Saving Alternative: What are Biosimilars?

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

MARCH 17, 2022

Lack of information based on clinical data can mean providers and patients decide against treating underlying conditions, “which in some cases may result in more harm” to the parent and the fetus than if they had received treatment. Subscribe to our life sciences news for ongoing visibility of FDA and industry updates.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10